The goal of recent research was to explore how a specific cannabis extract causes cell death in melanoma, a form of skin cancer. Researchers from Australia focused on the molecular mechanisms of how cannabis impacts melanoma cells. Their findings, published in January 2024, confirm that the Cannabis sativa extract PHEC-66 (primarily cannabidiol or CBD) significantly inhibits cancer cell growth and promotes their death.
The experiment revealed that cannabis extract:
- Prevents the formation of new cancer cells (metastases)
- Inhibits the spread of cancer cells across the body
- Causes cancer cells to become immobilized
- Induces apoptosis, disrupting cancer cell function and leading to cell death
As explained by Nazim Nassar, co-author of the study, "The damage caused to melanoma cells prevents them from dividing, triggering programmed cell death known as apoptosis." Cannabis already has clinical applications for treating anxiety, chronic pain, and epilepsy, and studies like this one offer new perspectives on its potential to fight cancer.
Melanoma is particularly known for its resistance to conventional treatments and its tendency to metastasize. The researchers urge further preclinical studies to fully understand the potential of cannabinoids as supplementary therapies in drug development.
It's important to explore the full potential of cannabis extracts, especially as a promising treatment for various cancers, including melanoma.